Compounds > sclareol
Page last updated: 2024-09-04

sclareol and Bone Loss, Perimenopausal

sclareol has been researched along with Bone Loss, Perimenopausal in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bai, X; Jennifer, T; Jin, H; Liu, Q; Miao, J; Qiu, H; Shao, Z; Wang, C; Wang, Q; Wang, X; Xu, J; Zhang, Z1

Other Studies

1 other study(ies) available for sclareol and Bone Loss, Perimenopausal

ArticleYear
Sclareol prevents ovariectomy-induced bone loss in vivo and inhibits osteoclastogenesis in vitro via suppressing NF-κB and MAPK/ERK signaling pathways.
    Food & function, 2019, Oct-16, Volume: 10, Issue:10

    Topics: Animals; Diterpenes; Female; Humans; MAP Kinase Signaling System; Mice, Inbred C57BL; NF-kappa B; Osteoclasts; Osteogenesis; Osteoporosis, Postmenopausal

2019